These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9813658)
1. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase. Haberkorn U; Bellemann ME; Gerlach L; Morr I; Trojan H; Brix G; Altmann A; Doll J; van Kaick G Gene Ther; 1998 Jul; 5(7):880-7. PubMed ID: 9813658 [TBL] [Abstract][Full Text] [Related]
2. Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir. Haberkorn U; Altmann A; Morr I; Germann C; Oberdorfer F; van Kaick G J Nucl Med; 1997 Jul; 38(7):1048-54. PubMed ID: 9225789 [TBL] [Abstract][Full Text] [Related]
3. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase. Haberkorn U; Altmann A; Kamencic H; Morr I; Traut U; Henze M; Jiang S; Metz J; Kinscherf R Eur J Nucl Med; 2001 Nov; 28(11):1690-6. PubMed ID: 11702112 [TBL] [Abstract][Full Text] [Related]
4. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. Haberkorn U; Altmann A; Morr I; Knopf KW; Germann C; Haeckel R; Oberdorfer F; van Kaick G J Nucl Med; 1997 Feb; 38(2):287-94. PubMed ID: 9025757 [TBL] [Abstract][Full Text] [Related]
5. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951 [TBL] [Abstract][Full Text] [Related]
6. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. Haberkorn U; Bellemann ME; Altmann A; Gerlach L; Morr I; Oberdorfer F; Brix G; Doll J; Blatter J; van Kaick G J Nucl Med; 1997 Aug; 38(8):1215-21. PubMed ID: 9255154 [TBL] [Abstract][Full Text] [Related]
8. Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Yaghoubi SS; Barrio JR; Namavari M; Satyamurthy N; Phelps ME; Herschman HR; Gambhir SS Cancer Gene Ther; 2005 Mar; 12(3):329-39. PubMed ID: 15592447 [TBL] [Abstract][Full Text] [Related]
9. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948 [TBL] [Abstract][Full Text] [Related]
11. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410 [TBL] [Abstract][Full Text] [Related]
12. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy. Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278 [TBL] [Abstract][Full Text] [Related]
13. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027 [TBL] [Abstract][Full Text] [Related]
14. Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport. Buursma AR; van Dillen IJ; van Waarde A; Vaalburg W; Hospers GA; Mulder NH; de Vries EF Br J Cancer; 2004 Dec; 91(12):2079-85. PubMed ID: 15599382 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration. Klatzmann D Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175 [TBL] [Abstract][Full Text] [Related]
16. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
17. Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats. Engelmann C; Panis Y; Bolard J; Diquet B; Fabre M; Nagy H; Soubrane O; Houssin D; Klatzmann D Hum Gene Ther; 1999 Jun; 10(9):1545-51. PubMed ID: 10395379 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine. Haberkorn U; Bellemann ME; Brix G; Kamencic H; Morr I; Traut U; Altmann A; Doll J; Blatter J; Kinscherf R Eur J Nucl Med; 2001 Apr; 28(4):418-25. PubMed ID: 11357491 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model. Zhu R; Chen D; Lin D; Lu F; Yin J; Li N Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402 [TBL] [Abstract][Full Text] [Related]
20. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene. Kim YG; Bi W; Feliciano ES; Drake RR; Stambrook PJ Cancer Gene Ther; 2000 Feb; 7(2):240-6. PubMed ID: 10770632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]